Abstract:Boron-dipyrromethene (BODIPY) dyes have aroused considerable interest in cancer theranostics over the past decade because of robust photochemical properties. Although a large number of BODIPY photosensitizers (PSs) containing heavy atoms have been reported, the development of heavy-atom-free BODIPY PSs for oncologic photodynamic therapy (PDT) has been limited mainly by the uncertainty in intersystem crossing (ISC) mechanisms, unbalanced phototoxic effectiveness and fluorescence quantum yields, and aggregation-caused quenching effects. In addition, the lack of extensive in vivo studies of heavy-atom-free BODIPY PSs continues to limit clinical application. Herein, novel heavy-atom-free BODIPY-phenoxazine triads (BDP-8/BDP-9) that generate efficient excited triplet states via radical pair intersystem crossing (RP-ISC) followed by triplet charge recombination were developed for use in fluorescence image-guided PDT. BDP-8/BDP-9 exhibited high molar absorption coefficients, prominent aggregation-induced emission, and excellent singlet oxygen generation capability upon light irradiation. The corresponding BODIPY nanoparticles (BDP-8/BDP-9 NPs) with bright red emission, considerable phototoxicity, and excellent tumor-targeting ability were simply prepared by encapsulating BDP-8/BDP-9 PSs in a polymeric matrix. More importantly, the results of both in vitro and in vivo experiments demonstrated the considerable potential of BDP-8 NPs for image-guided photodynamic cancer therapy. This study may inspire the development of potential BODIPY-based nanoagents for cancer theranostics.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.chemmater.1c02776.Experimental data; synthesis, nanoparticle preparation, photophysical measurements, and reactive oxygen species measurements of BDP-8/BDP-9; in vitro and in vivo studies of BDP-8/BDP-9 NPs; 1H and 13C NMR spectra of all compounds; UV–vis absorption and PL spectra; fluorescence images; computational details, calculated electronic transition energies; energy gap between single and triplet states; spin-orbit coupling constant; and intersystem crossing rate constant (PDF)This article has not yet been cited by other publications.

Triphenylphosphonium-functionalized dimeric BODIPY-based nanoparticles for mitochondria-targeting photodynamic therapy

Optimizing Mitochondrial-Targeting Groups of Positively-Charged BODIPY Nanoparticles for Enhanced Photodynamic Therapy

Mitochondria-targeting BODIPY-loaded Micelles As Novel Class of Photosensitizer for Photodynamic Therapy

Cationic BODIPY Photosensitizers for Mitochondrion-Targeted Fluorescence Cell-Imaging and Photodynamic Therapy

Potent BODIPY-based photosensitisers for selective mitochondrial dysfunction and effective photodynamic therapy

Novel BODIPY-based Nano-Biomaterials with Enhanced D-A-D Structure for NIR-triggered Photodynamic and Photothermal Therapy

Biocompatible conjugated porphyrin nanoparticles with photodynamic/photothermal performances in cancer therapy

The halogen effect of bis-truxene substituted BODIPY photosensitizers for potential photodynamic therapy

Novel Naphthalimide Bridged Zinc Porphyrin/bodipy Nanomaterials with D-A Structure for Photodynamic Therapy

A Ph-Activatable Nanoparticle for Dual-Stage Precisely Mitochondria-Targeted Photodynamic Anticancer Therapy.

Access to the Triplet Excited States of Heavy-Atom-Free Boron-Dipyrromethene Photosensitizers via Radical Pair Intersystem Crossing for Image-Guided Tumor-Targeted Photodynamic Therapy

NIR-Absorbing Tetraphenylethene-Containing bisBODIPY Nanoplatforms Demonstrate Effective Lysosome-Targeting and Combinational Phototherapy

Enhanced Photodynamic Efficiency Achieved Via a Dual-Targeted Strategy Based on Photosensitizer/Micelle Structure

BODIPY nanoparticles functionalized with lactose for cancer-targeted and fluorescence imaging-guided photodynamic therapy

A BODIPY-modified polymeric micelle for sustaining enhanced photodynamic therapy

Single molecular-based nanoparticles with aggregation-induced emission characteristics for fluorescence imaging and efficient cancer phototherapy

Discovery of Subcellular-Targeted Aza-BODIPY Photosensitizers for Efficient Photodynamic Antitumor Therapy.

Synthesis and evaluation of novel mitochondria-targeted, water-soluble phenoxazine-porphyrins for efficient photodynamic therapy

Cyclometalated iridium(iii) complex nanoparticles for mitochondria-targeted photodynamic therapy

pH-Sensitive and Lysosome Targetable Photosensitizers Based on BODIPYs

All-in-one phototheranostics based on BTP-4F-DMO nanoparticles for NIR-II fluorescence/photoacoustic dual-mode imaging and combinational therapy